ContributorsPublishersAdvertisers

Dr. Gershenson on the Results of the MILO Trial in Low-Grade Serous Ovarian Cancer

onclive.com
 2022-01-24

David M. Gershenson, MD, discusses the results of the phase 3 MILO trial in low-grade serous ovarian cancer. David M. Gershenson, MD, professor of gynecologic oncology, Department of Gynecologic Oncology and Reproductive Medicine, Division of...

www.onclive.com

Comments / 0

Comments / 0